Press Release
Contact: Cassandra Cranston |
Phone: (919) 549-7500 |
Industry Pioneers, Experienced Investor Headline CED’s MedTech 2008 Conference
Event is the only one of its kind in the Mid-Atlantic/Southeast region.
Research Triangle Park, N.C., February 20, 2008 – Two early leaders of the nation’s medical device industry and an experienced industry investment banker will headline the Council for Entrepreneurial Development’s MedTech 2008 on March 6, 2008. The featured speakers are Ronald W. Dollens of Guidant Corporation; Richard S. Stack, M.D., of Synecor, LLC; and Jeff Hoffman of J.P. Morgan Securities, Inc. The conference, the only event of its kind in the region, will bring together advanced medical technology companies, investors and service providers from across the nation to learn, partner and network. It will be held at the Fuqua School of Business in Durham, N.C.
“These gentlemen have been company builders and key investors who really know where the industry’s going,” says Peyton Anderson, CEO of local company Affinergy, developer of site-specific biological delivery systems, and a member of the MedTech 2008 steering committee. “They’re going to give us a great view into what the future holds for the medical technology industry and what it will take to get there.”
Hoffman, managing director and head of west coast healthcare investment banking for J.P. Morgan Securities Inc., will discuss the current investment tone of the advanced medical technology industry from 9 a.m. to 9:45 a.m. He will draw examples from more than 16 years’ experience in the full range of investment banking activities including financial advisory services, mergers and acquisitions, equity and debt financings, and venture capital investments.
Dollens, Guidant’s former president and CEO, will discuss the future of the health care industry from a governmental policy perspective from 9:45 a.m. to 10:30 a.m. He also will recount the rise of Guidant, the manufacturer of cardiovascular devices he led for almost 20 years, and its acquisition in 2006 to Boston Scientific and Abbott in a $27-billion transaction. During Dollens’ tenure, Guidant became one of the largest medical technology companies in the world, introducing several breakthrough technologies. Prior to Guidant, he served as president of Eli Lilly and Co.'s Medical Devices and Diagnostics Division and worked for Advanced Cardiovascular Systems Inc. of Santa Clara, Calif.
Stack is president of Synecor, LLC, the RTP-based medical technology business generator and financial incubator. From noon to 1:30 p.m., Stack will cover the catalysts for the development of medical technology hubs around the country and how Synecor could fulfill that role for RTP. In the past six years, Stack has co-founded and invested in five major medical device companies, including Synecor itself, with a combined current valuation of over $675 million. He had key early patents in the innovative bare-metal stent space and also invented the bioresorbable stent product.
In addition to the main speakers, MedTech 2008 will feature expert commentaries and networking opportunities along with these panel discussions:
- Alternatives to Growing a Medical Device Company (10:45 a.m. to noon)
- Convergent Technologies Changing the Face of Medicine (1:45 p.m. to 3:00 p.m.)
- Global Clinical Trials (3 p.m. to 4 p.m.)
Registration is $99 for CED members, $149 for non-members and $49 for students. To register, visit www.cednc.org/medtech.
###